Yan G[au] - Search Results

Year	Number of Results
1975	1
1980	2
1981	1
1982	2
1985	3
1986	6
1987	4
1988	4
1989	5
1990	4
1991	7
1992	10
1993	9
1994	8
1995	14
1996	11
1997	20
1998	19
1999	19
2000	30
2001	22
2002	30
2003	60
2004	46
2005	72
2006	72
2007	62
2008	87
2009	100
2010	130
2011	140
2012	166
2013	208
2014	186
2015	236
2016	239
2017	254
2018	271
2019	336
2020	352
2021	403
2022	235

1

Inflammation and tumor progression: signaling pathways and targeted intervention.

Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Zhao H, et al. Among authors: yan g. Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5. Signal Transduct Target Ther. 2021. PMID: 34248142 Free PMC article.

2

Ferritinophagy and ferroptosis in cardiovascular disease: Mechanisms and potential applications.

Qin Y, Qiao Y, Wang D, Tang C, Yan G. Qin Y, et al. Among authors: yan g. Biomed Pharmacother. 2021 Sep;141:111872. doi: 10.1016/j.biopha.2021.111872. Epub 2021 Jul 7. Biomed Pharmacother. 2021. PMID: 34246187 Free article. Review.

3

YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration.

Yang Z, Yan G, Zheng L, Gu W, Liu F, Chen W, Cui X, Wang Y, Yang Y, Chen X, Fu Y, Xu X. Yang Z, et al. Among authors: yan g. Oncoimmunology. 2021 Jun 23;10(1):1938890. doi: 10.1080/2162402X.2021.1938890. Oncoimmunology. 2021. PMID: 34221701 Free PMC article.

4

In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy.

Dai M, Yan G, Wang N, Daliah G, Edick AM, Poulet S, Boudreault J, Ali S, Burgos SA, Lebrun JJ. Dai M, et al. Among authors: yan g. Nat Commun. 2021 May 24;12(1):3055. doi: 10.1038/s41467-021-23316-4. Nat Commun. 2021. PMID: 34031411 Free PMC article.

5

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.

Zeng J, Li X, Sander M, Zhang H, Yan G, Lin Y. Zeng J, et al. Among authors: yan g. Front Immunol. 2021 Oct 5;12:721830. doi: 10.3389/fimmu.2021.721830. eCollection 2021. Front Immunol. 2021. PMID: 34675919 Free PMC article. Review.

6

Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.

Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, Nee R. Thurlow JS, et al. Among authors: yan g. Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550. Epub 2021 Mar 22. Am J Nephrol. 2021. PMID: 33752206 Free PMC article. Review.

7

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma.

Yan G, An Y, Xu B, Wang N, Sun X, Sun M. Yan G, et al. Front Oncol. 2021 May 17;11:670490. doi: 10.3389/fonc.2021.670490. eCollection 2021. Front Oncol. 2021. PMID: 34079761 Free PMC article.

8

Discovery of a PROTAC targeting ALK with in vivo activity.

Yan G, Zhong X, Yue L, Pu C, Shan H, Lan S, Zhou M, Hou X, Yang J, Li R. Yan G, et al. Eur J Med Chem. 2021 Feb 15;212:113150. doi: 10.1016/j.ejmech.2020.113150. Epub 2021 Jan 2. Eur J Med Chem. 2021. PMID: 33453602

9

Role of ferroptosis in the process of diabetes-induced endothelial dysfunction.

Luo EF, Li HX, Qin YH, Qiao Y, Yan GL, Yao YY, Li LQ, Hou JT, Tang CC, Wang D. Luo EF, et al. Among authors: yan gl. World J Diabetes. 2021 Feb 15;12(2):124-137. doi: 10.4239/wjd.v12.i2.124. World J Diabetes. 2021. PMID: 33594332 Free PMC article.

10

Ribosome 18S m⁶A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.

Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y, Cai J, Xie J, Song Y, Chen J, Zhang L, Yan G, Zhang W, Gao H, Han JJ, Qu Q, Ma H, Tian Y, Lan F. Rong B, et al. Among authors: yan g. Cell Rep. 2020 Dec 22;33(12):108544. doi: 10.1016/j.celrep.2020.108544. Cell Rep. 2020. PMID: 33357433 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results